These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 11112341

  • 1. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
    Maquoi E, Frankenne F, Noël A, Krell HW, Grams F, Foidart JM.
    Exp Cell Res; 2000 Dec 15; 261(2):348-59. PubMed ID: 11112341
    [Abstract] [Full Text] [Related]

  • 2. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 3. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM, Kim A, Oh JH, Chung AS.
    Carcinogenesis; 2007 Apr 01; 28(4):837-47. PubMed ID: 17071627
    [Abstract] [Full Text] [Related]

  • 4. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 01; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 5. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
    Maquoi E, Munaut C, Colige A, Lambert C, Frankenne F, Noël A, Grams F, Krell HW, Foidart JM.
    Exp Cell Res; 2002 Apr 15; 275(1):110-21. PubMed ID: 11925109
    [Abstract] [Full Text] [Related]

  • 8. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW.
    Lab Invest; 1997 May 15; 76(5):651-60. PubMed ID: 9166284
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS.
    Lab Invest; 2004 Jan 15; 84(1):8-20. PubMed ID: 14631378
    [Abstract] [Full Text] [Related]

  • 10. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
    Lafleur MA, Forsyth PA, Atkinson SJ, Murphy G, Edwards DR.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):463-73. PubMed ID: 11401482
    [Abstract] [Full Text] [Related]

  • 11. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C, Chen Z, Li Z, Cen J.
    Leuk Res; 2010 Aug 30; 34(8):1083-90. PubMed ID: 20138666
    [Abstract] [Full Text] [Related]

  • 12. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA.
    J Cell Physiol; 1996 May 30; 167(2):333-40. PubMed ID: 8613475
    [Abstract] [Full Text] [Related]

  • 13. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA.
    Cancer Res; 2001 Aug 15; 61(16):6264-75. PubMed ID: 11507081
    [Abstract] [Full Text] [Related]

  • 14. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A.
    Cancer Res; 1998 Aug 15; 58(16):3743-50. PubMed ID: 9721888
    [Abstract] [Full Text] [Related]

  • 15. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, Kim KW.
    Cancer Res; 1996 May 15; 56(10):2281-4. PubMed ID: 8625299
    [Abstract] [Full Text] [Related]

  • 16. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
    Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M, Sugioka Y.
    Cancer Res; 1995 Jul 01; 55(13):2927-35. PubMed ID: 7796421
    [Abstract] [Full Text] [Related]

  • 17. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.
    Cancer Res; 2005 Oct 01; 65(19):8801-8. PubMed ID: 16204050
    [Abstract] [Full Text] [Related]

  • 18. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.
    Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY.
    Exp Cell Res; 2001 Feb 15; 263(2):209-23. PubMed ID: 11161720
    [Abstract] [Full Text] [Related]

  • 19. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M, Miyamori H, Yamashita J, Sato H.
    Cancer Res; 2003 Jun 15; 63(12):3364-9. PubMed ID: 12810672
    [Abstract] [Full Text] [Related]

  • 20. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia.
    Fähling M, Perlewitz A, Doller A, Thiele BJ.
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct 15; 139(1-3):119-26. PubMed ID: 15556073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.